Who
Siddhartha Kadia
President and CEO
Company insider
Files Form 4 as: President and CEO, Mesa Laboratories; Chief Executive Officer, Bruker Cellular Analysis; Director, Nuvasive; Director, IsoPlexis; Director and Other, Newport; Director, Volcano.
In numbers
- Trades disclosed
- 55
- Buys
- 1
- Sells
- 0
- Bought
- $1.6M
- Sold
- $0
- Companies
- 6
- Companies where not an officer
- 4
- First trade
- 29 Mar 2013
- Last trade
- 13 Aug 2026
- Last filed
- 17 Aug 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 13 Aug 2026filed 17 Aug 2026 | MLAB Mesa LaboratoriesLife-science tools | SEC FORM 4 Bought | $800K7,093 at $112.80 | filing |
| 13 Aug 2026filed 17 Aug 2026 | MLAB Mesa LaboratoriesLife-science tools | SEC FORM 4 Bought | $800K7,093 at $112.80 | filing |
| 14 Apr 2026filed 19 May 2026 | MLAB Mesa Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code A | —35,236 at $0.00 | filing |
| 14 Apr 2026filed 19 May 2026 | MLAB Mesa Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code A | —35,236 at $0.00 | filing |
| 14 Apr 2026filed 24 Apr 2026 | MLAB Mesa Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code A | —34,807 at $0.00 | filing |
| 14 Apr 2026filed 24 Apr 2026 | MLAB Mesa Laboratoriesoption or derivative · Life-science tools | SEC FORM 4 Code A | —34,807 at $0.00 | filing |
| 2 Oct 2023filed 3 Oct 2023 | Bruker Cellular Analysis | SEC FORM 4 Code D | —595,395 | filing |
| 2 Oct 2023filed 3 Oct 2023 | Bruker Cellular Analysis | SEC FORM 4 Code D | —645,294 | filing |
| 1 Sep 2023filed 5 Sep 2023 | Nuvasiveoption or derivative | SEC FORM 4 Code D | —3,788 at $0.00 | filing |
| 1 Sep 2023filed 5 Sep 2023 | Nuvasiveoption or derivative | SEC FORM 4 Code D | —4,816 at $0.00 | filing |
| 1 Sep 2023filed 5 Sep 2023 | Nuvasive | SEC FORM 4 Code D | —3,739 | filing |
| 24 Aug 2023filed 28 Aug 2023 | PhenomeX | SEC FORM 4 Code G | —645,294 at $0.00 | filing |
| 24 Aug 2023filed 28 Aug 2023 | PhenomeX | SEC FORM 4 Code G | —645,294 at $0.00 | filing |
| 9 Jun 2023filed 12 Jun 2023 | Nuvasiveoption or derivative | SEC FORM 4 Code A | —4,816 at $0.00 | filing |
| 3 Mar 2023filed 7 Mar 2023 | Berkeley Lights | SEC FORM 4 Code A | —317,029 at $0.00 | filing |
| 9 Dec 2022filed 13 Dec 2022 | Berkeley Lights | SEC FORM 4 Code F | $98K36,975 at $2.64 | filing |
| 7 Dec 2022filed 9 Dec 2022 | Berkeley Lights | SEC FORM 4 Code F | $380150 at $2.53 | filing |
| 9 Sep 2022filed 13 Sep 2022 | Berkeley Lights | SEC FORM 4 Code F | $116K29,200 at $3.96 | filing |
| 7 Sep 2022filed 9 Sep 2022 | Berkeley Lights | SEC FORM 4 Code F | $2,064561 at $3.68 | filing |
| 16 Jun 2022filed 21 Jun 2022 | IsoPlexisoption or derivative | SEC FORM 4 Code A | —89,047 at $0.00 | filing |
News
Mesa Laboratories (NASDAQ:MLAB) and CryoPort (NASDAQ:CYRX) Head-To-Head ReviewMLAB · tickerreport.com · 25 Oct 2026
0 headlines in the last 90 days name Siddhartha Kadia; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.